These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

532 related articles for article (PubMed ID: 810648)

  • 21. [Long-term comparative studies on gold, D-penicillamine, and NSAIDs for the treatment of early rheumatoid arthritis. 1. Evaluation of one year's treatment].
    Azuma T; Sugawara S; Maeda A; Miyauchi T; Aritomi H
    Ryumachi; 1986 Jun; 26(3):200-9. PubMed ID: 3097838
    [No Abstract]   [Full Text] [Related]  

  • 22. Hematuria in patients with rheumatoid arthritis receiving gold and D-penicillamine.
    Leonard PA; Bienz SR; Clegg DO; Ward JR
    J Rheumatol; 1987 Feb; 14(1):55-9. PubMed ID: 3106632
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Laboratory findings in patients with rheumatoid arthritis during D-penicillamine- and goldtherapy (author's transl)].
    Stojan B; Hasler F
    Schweiz Rundsch Med Prax; 1977 Nov; 66(45):1435-6. PubMed ID: 928308
    [No Abstract]   [Full Text] [Related]  

  • 24. [D-penicillamine in the treatment of rheumatoid polyarthritis. 104 cases with a 5-year follow-up].
    Valat JP; Fouquet B; Eveleigh MC; Chantreuil C; Lalot F
    Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):7-12. PubMed ID: 3704516
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Gold compounds and D-penicillamine for therapy of rheumatoid arthritis].
    Miyamoto S; Inoue T
    Nihon Rinsho; 1992 Mar; 50(3):515-20. PubMed ID: 1588740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A long-term clinical analysis of the rheumatoid patients treated by a combination of GST and CCA].
    Minami M; Kaneda K
    Ryumachi; 1995 Oct; 35(5):780-91. PubMed ID: 8594657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of antirheumatic drugs on circulating immune complexes in rheumatoid arthritis.
    Forster PJ; McConkey B
    Q J Med; 1986 Jan; 58(225):29-42. PubMed ID: 2871585
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Toxicity of longterm low dose D-penicillamine therapy in rheumatoid arthritis. Cooperative Systematic Studies of Rheumatic Disease Group.
    J Rheumatol; 1987 Feb; 14(1):67-73. PubMed ID: 2952797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Levamisole in rheumatoid arthritis: a comparison with D-penicillamine.
    Mowat AG; Mowat AM
    J Rheumatol; 1981; 8(4):575-80. PubMed ID: 7299760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Ceruloplasmin and immunoglobulins under controlled D-penicillamine therapy in rheumatoid arthritis].
    Schmidt KL; Ott VR
    Z Rheumatol; 1976; 35(3-4):154-63. PubMed ID: 1266422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The long term treatment of rheumatoid arthritis with D-penicillamine].
    Krüger HH
    Verh Dtsch Ges Rheumatol; 1969; 1():387-94. PubMed ID: 4997350
    [No Abstract]   [Full Text] [Related]  

  • 32. [The drug spectrum in rheumatoid arthritis therapy].
    Fellinger K
    Acta Med Austriaca; 1975; 2(4):105-10. PubMed ID: 1224926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Two-phase course of IgM and rheumatoid factors during D-penicillamine therapy].
    Stojan B; Hasler F
    Z Rheumatol; 1977; 36(5-6):194-9. PubMed ID: 302538
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term treatment of rheumatoid arthritis with fenclofenac or gold: a controlled, single blind trial comparing clinical and biochemical parameters.
    Lund B; Graae A; Sonne I; Andersen RB
    Eur J Rheumatol Inflamm; 1983; 6(3):279-87. PubMed ID: 6391933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Prophylaxis and therapeutics of iatrogenic consequences, produced by treatment of rheumatoid arthritis (author's transl)].
    Vanslype J; Tritsmans E; Verstraete J
    Acta Rhumatol Belg; 1978; 2(1-2):22-33. PubMed ID: 751468
    [No Abstract]   [Full Text] [Related]  

  • 36. [Actual results of the rheumatoid polyarthritis therapy with immuno-suppressive drugs: d-penicillamine and cytostatics (author's transl)].
    Barnes CG
    Schweiz Rundsch Med Prax; 1977 Nov; 66(44):1412-20. PubMed ID: 928306
    [No Abstract]   [Full Text] [Related]  

  • 37. Penicillamine and other remittive agents in rheumatoid arthritis: comparisons and interaction.
    Stein HB; Ruedy J; Atkins CJ; Offer RC
    Clin Invest Med; 1984; 7(1):59-63. PubMed ID: 6723126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Upper and lower airway disease in penicillamine treated patients with rheumatoid arthritis.
    Wolfe F; Schurle DR; Lin JJ; Polland SM; Smith TW; Montgomery-Short R; James DL
    J Rheumatol; 1983 Jun; 10(3):406-10. PubMed ID: 6887164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The relationship between D-penicillamine--induced proteinuria and prior gold nephropathy.
    Billingsley LM; Stevens MB
    Johns Hopkins Med J; 1981 Feb; 148(2):64-7. PubMed ID: 7206401
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of auranofin, gold sodium thiomalate, and D-penicillamine in rheumatoid arthritis: a progress report.
    Barraclough D; Brook A; Brooks P; Boyden K; Thomas D; Tymms K
    J Rheumatol Suppl; 1982; 8():197-200. PubMed ID: 6813485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.